Drug class in one race
SGLT2 drugs for Type 2 Diabetes
11 tracked SGLT2 drugs in the Type 2 Diabetes race. The class explanation lives on the SGLT2 page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
5 approved / phase 43 Phase 32 Phase 21 Phase 1
Head-to-head evidence: Bexagliflozin vs Canagliflozin · Bexagliflozin vs DA-2811 · Bexagliflozin vs DWP16001 · Bexagliflozin vs Dapagliflozin · Bexagliflozin vs Empagliflozin · Bexagliflozin vs Ertugliflozin